0
0
8/10/23 at 8:07pm
Organization
Nature.com
33 words
0
Comments
Clinical-trial data suggest that semaglutide, sold under the name Wegovy, slashes risk of heart attacks and other cardiovascular incidents.
You are the first to view
https://www.nature.com/articles/d41586-023-02528-2
Create an account
or login to join the discussion